Please ensure Javascript is enabled for purposes of website accessibility

Not Even James Bond Is Immune to Coronavirus

By Jon Quast - Mar 4, 2020 at 4:30PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The release of "No Time to Die," the 25th movie in the iconic 007 franchise, is being postponed until November.

If you love the fast cars, cool gadgets, and shaken (not stirred) dry vodka martinis of iconic MI6 agent James Bond, you're not going to like this: The premiere of Daniel Craig's fifth outing as 007, No Time To Die, has been delayed until November in light of the COVID-19 epidemic. 

An empty movie theater

Image source: Getty Images.

The worldwide delay

The 25th movie in the James Bond franchise was set to be distributed internationally by Universal (which is owned by Comcast (CMCSA 2.68%) through its subsidiary NBC) this April. However, on the official James Bond website, the announcement was made that the upcoming film will be delayed due to the coronavirus. Many movie theaters (and other businesses in China) are closed, making a launch in the world's second-most-important movie market impractical for now. And as COVID-19 spreads globally, it's possible that movie theater chains in other countries could follow suit.

No Time To Die isn't the first movie release put on hold because of the coronavirus. Recently, Disney announced that it would delay the release of its live-action remake of Mulan -- but only in China. The movie is still slated to arrive in U.S. theaters on March 27, right on schedule. By contrast, No Time To Die is being delayed worldwide.

But it's not surprising. James Bond films perform well at the global box office. The last two, Skyfall and Spectre, hauled in $1.1 billion and $880 million at the box office respectively. But Skyfall made more than $804 million (72.5%) of its gross in non-U.S. markets, and Spectre pulled in $681 million (77.3%) internationally.

Moving No Time To Die to November gives it a better chance to play to larger audiences in a wider number of theaters. Autumn is also a better time to compete for ticket sales than the blockbuster-heavy summer months.

The film is now scheduled for a Nov. 25 release in the U.S.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Comcast Corporation Stock Quote
Comcast Corporation
$40.29 (2.68%) $1.05
The Walt Disney Company Stock Quote
The Walt Disney Company
$96.14 (1.84%) $1.74

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/02/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.